SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-002592
Filing Date
2021-01-27
Accepted
2021-01-27 16:00:37
Documents
13
Period of Report
2021-01-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-8k_20210121.htm   iXBRL 8-K 41347
2 EX-3.1 asmb-ex31_15.htm EX-3.1 246661
  Complete submission text file 0001564590-21-002592.txt   473458

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asmb-20210121.xsd EX-101.SCH 5788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20210121_lab.xml EX-101.LAB 19482
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20210121_pre.xml EX-101.PRE 11636
6 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20210121_htm.xml XML 3575
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 21559679
SIC: 2834 Pharmaceutical Preparations